(Q26866450)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367913%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

1 reference

title

Systematic review of biomarkers to monitor therapeutic response in leishmaniasis (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367913%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

0 references

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367913%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

3

Jos H Beijnen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367913%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

4

Jan H M Schellens

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367913%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Manica Balasegaram

series ordinal

2

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367913%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Anke E Kip

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367913%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Peter J de Vries

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367913%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

1 reference

3 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367913%20AND%20SRC:MED&resulttype=core&format=json

Antimicrobial Agents and Chemotherapy

22 February 2020

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367913%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

59

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367913%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

1

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367913%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

1-14

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367913%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Interventions for American cutaneous and mucocutaneous leishmaniasis

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Interventions for Old World cutaneous leishmaniasis

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

A novel Leishmania infantum nuclear phosphoprotein Lepp12 which stimulates IL1-beta synthesis in THP-1 transfectants

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Serum neopterin concentrations during treatment of leishmaniasis: useful as test of cure?

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Differential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclass antibodies in Indian kala-azar patients after chemotherapy

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Prognostic value of serum C-reactive protein in kala-azar

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Dynamics of parasite clearance in cutaneous leishmaniasis patients treated with miltefosine

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Development of a reverse transcriptase loop-mediated isothermal amplification (LAMP) assay for the sensitive detection of Leishmania parasites in clinical samples

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Advances in leishmaniasis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Comparison of immune regulatory factors in acute and chronic lesions of cutaneous leishmaniasis due to Leishmania major

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Mapping B-cell epitopes for the peroxidoxin of Leishmania (Viannia) braziliensis and its potential for the clinical diagnosis of tegumentary and visceral leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Cytokine profiles amongst Sudanese patients with visceral leishmaniasis and malaria co-infections

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Interleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

SOD1 plasma level as a biomarker for therapeutic failure in cutaneous leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and Nepal

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Alteration of the serum biomarker profiles of visceral leishmaniasis during treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

rKLO8, a novel Leishmania donovani - derived recombinant immunodominant protein for sensitive detection of visceral leishmaniasis in Sudan

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

High levels of soluble CD40 ligand and matrix metalloproteinase-9 in serum are associated with favorable clinical evolution in human visceral leishmaniasis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Towards a more precise serological diagnosis of human tegumentary leishmaniasis using Leishmania recombinant proteins

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Serum cytokines associated with severity and complications of kala-azar.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Arginase activity - a marker of disease status in patients with visceral leishmaniasis in ethiopia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Arginase activity in the blood of patients with visceral leishmaniasis and HIV infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Testing urine samples with rK39 strip as the simplest non-invasive field diagnosis for visceral leishmaniasis: an early report from eastern India

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Local increase of arginase activity in lesions of patients with cutaneous leishmaniasis in Ethiopia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Diagnosis of visceral leishmaniasis: developments over the last decade

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Leishmaniasis chemotherapy--challenges and opportunities

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Evidence that lipopolisaccharide may contribute to the cytokine storm and cellular activation in patients with visceral leishmaniasis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Foxp3 and IL-10 expression correlates with parasite burden in lesional tissues of post kala azar dermal leishmaniasis (PKDL) patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Study of parasite kinetics with antileishmanial drugs using real-time quantitative PCR in Indian visceral leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Drug discovery and development for neglected diseases: the DNDi model

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Identification and Characterization of a Novel, 37-Kilodalton Leishmania donovani antigen for diagnosis of Indian visceral leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Design, development and evaluation of rK28-based point-of-care tests for improving rapid diagnosis of visceral leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Viability and burden of Leishmania in extralesional sites during human dermal leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Designing and reporting clinical trials on treatments for cutaneous leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

The rK39 strip test is non-predictor of clinical status for kala-azar

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Detection of Leishmania in unaffected mucosal tissues of patients with cutaneous leishmaniasis caused by Leishmania (Viannia) species.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Comparative study of serologic tests for the diagnosis of asymptomatic visceral leishmaniasis in an endemic area.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

PCR and direct agglutination as Leishmania infection markers among healthy Nepalese subjects living in areas endemic for Kala-Azar

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Diagnostic accuracy of a new Leishmania PCR for clinical visceral leishmaniasis in Nepal and its role in diagnosis of disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

The cancer biomarker problem

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Treatment assessment by monitoring parasite load in skin biopsies from patients with cutaneous leishmaniasis, using quantitative nucleic acid sequence-based amplification

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and r

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Immunologic tests in patients after clinical cure of visceral leishmaniasis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Amastin peptide-binding antibodies as biomarkers of active human visceral leishmaniasis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Comparison of new diagnostic tools for management of pediatric Mediterranean visceral leishmaniasis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Quantification of the response to miltefosine treatment for visceral leishmaniasis by QT-NASBA.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Quantitative nucleic acid sequence-based assay as a new molecular tool for detection and quantification of Leishmania parasites in skin biopsy samples

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Recombinant leishmania antigens for serodiagnosis of visceral leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

PCR diagnosis and characterization of Leishmania in local and imported clinical samples.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Antimonial therapy induces circulating proinflammatory cytokines in patients with cutaneous leishmaniasis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Laboratory diagnosis of visceral leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Antigenuria in visceral leishmaniasis: detection and partial characterisation of a carbohydrate antigen

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Enzyme-linked immunosorbent assay for recombinant K39 antigen in diagnosis and prognosis of Indian visceral leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Latex agglutination test for the detection of urinary antigens in visceral leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Immunoglobulin subclass distribution and diagnostic value of Leishmania donovani antigen-specific immunoglobulin G3 in Indian kala-azar patients.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Use of PCR on lymph-node sample as test of cure of visceral leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

A comparison of intercostal and abdominal routes of splenic aspiration and bone marrow aspiration in the diagnosis of visceral leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Serum soluble markers in the evaluation of treatment in human visceral leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Evaluation of serum levels of soluble CD4, CD8 and beta 2-microglobulin in visceral human leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Soluble receptors for tumor necrosis factor as markers of disease activity in visceral leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Immunoglobulin G subclass-specific antileishmanial antibody responses in Indian kala-azar and post-kala-azar dermal leishmaniasis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Persistence of elevated levels of galactosyl-alpha(1-3)galactose antibodies in sera from patients cured of visceral leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Indoleamine 2,3-dioxygenase activity as a potential biomarker of immune suppression during visceral leishmaniasis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

In search of an ideal test for diagnosis and prognosis of kala-azar.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Increased levels of IL-10, IL-12, and IFN- in patients with visceral leishmaniasis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

High levels of C-reactive protein in the peripheral blood during visceral leishmaniasis predict subsequent development of post kala-azar dermal leishmaniasis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Cloning, characterization and serological evaluation of K9 and K26: two related hydrophilic antigens of Leishmania chagasi

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Serodiagnosis of cutaneous leishmaniasis: assessment of an enzyme-linked immunosorbent assay using a peptide sequence from gene B protein.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Interleukin 6 during active visceral leishmaniasis and after treatment

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

High C1q levels, low C1s/C1q ratios, and high levels of circulating immune complexes in kala-azar

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Specific IgE antibodies to Leishmania braziliensis in patients with mucocutaneous leishmaniasis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Pre- and post-treatment antibody levels in visceral leishmaniasis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Generation of cytokines in human visceral leishmaniasis: dissociation of endogenous TNF-alpha and IL-1 beta production.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Tumor necrosis factor (cachectin) in human visceral leishmaniasis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

The significance of serum soluble IL-2 receptor as a marker for active visceral leishmaniasis in Sicilian patients

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

An epitope-specific PCR test for diagnosis of Leishmania donovani infections.

31 May 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

A new PCR-ELISA for diagnosis of visceral leishmaniasis in blood of HIV-negative subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Urine antigen detection by latex agglutination test for diagnosis and assessment of initial cure of visceral leishmaniasis

21 January 2018

2 references

https://api.crossref.org/works/10.1128%2FAAC.04298-14

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Clinical utility of polymerase chain reaction-based detection of Leishmania in the diagnosis of American cutaneous leishmaniasis.

28 November 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Persistence of leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Improvement of the newly developed latex agglutination test (Katex) for diagnosis of visceral lieshmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Field validity, reproducibility and feasibility of diagnostic tests for visceral leishmaniasis in rural Nepal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Field evaluation of FD-DAT, rK39 dipstick and KATEX (urine latex agglutination) for diagnosis of visceral leishmaniasis in northwest Ethiopia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Comparative evaluation of parasitology and serological tests in the diagnosis of visceral leishmaniasis in India: a phase III diagnostic accuracy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Adenosine deaminase activity in sera of patients with visceral leishmaniasis in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Adenosine deaminase activity in sera of patients with visceral leishmaniasis in Nepal

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

In vivo and in vitro cytokine profiles and mononuclear cell subsets in Sicilian patients with active visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Microbial translocation induces an intense proinflammatory response in patients with visceral leishmaniasis and HIV type 1 coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Gene expression profile of cytokines and chemokines in skin lesions from Brazilian Indians with localized cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

High intralesional interleukin-10 messenger RNA expression in localized cutaneous leishmaniasis is associated with unresponsiveness to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Serum cytokine profile in the subclinical form of visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Mononuclear cell subpopulations and cytokine levels in human visceral leishmaniasis before and after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Multiplex analysis of circulating cytokines in the sera of patients with different clinical forms of visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

CD23 and IgE expression during the human immune response to cutaneous leishmaniasis: possible role in monocyte activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Severe visceral leishmaniasis in children: the relationship between cytokine patterns and clinical features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Increased levels of soluble interleukin-4 receptor in the sera of patients with visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Arginase I, Polyamine, and Prostaglandin E2Pathways Suppress the Inflammatory Response and Contribute to Diffuse Cutaneous Leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Antibodies against a Leishmania infantum peroxiredoxin as a possible marker for diagnosis of visceral leishmaniasis and for monitoring the efficacy of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Purification, characterization of O-acetylated sialoglycoconjugates-specific IgM, and development of an enzyme-linked immunosorbent assay for diagnosis and follow-up of indian visceral leishmaniasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

A cloned antigen (recombinant K39) of Leishmania chagasi diagnostic for visceral leishmaniasis in human immunodeficiency virus type 1 patients and a prognostic indicator for monitoring patients undergoing drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Atypical cutaneous leishmaniasis cases display elevated antigen-induced interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Anti-Leishmania chagasi immunoglobulin G3 detected by flow cytometry for early cure assessment in American visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Decrease in anti-Leishmania IgG3 and IgG1 after cutaneous leishmaniasis lesion healing is correlated with the time of clinical cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Antibody subclass profile against Leishmania braziliensis and Leishmania amazonensis in the diagnosis and follow-up of mucosal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Interferon (IFN)-gamma , tumor necrosis factor-alpha , interleukin-6, and IFN-gamma receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Correlation of parasitic load with interleukin-4 response in patients with cutaneous leishmaniasis due to Leishmania tropica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Alteration of Fas and Fas ligand expression during human visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Soluble CD26/CD30 levels in visceral leishmaniasis: markers of disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Impaired expression of CD26 compromises T-cell recruitment in human visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

In leishmaniasis due to Leishmania guyanensis infection, distinct intralesional interleukin-10 and Foxp3 mRNA expression are associated with unresponsiveness to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Serum antioxidant activities, malondialdehyde and nitric oxide levels in human cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Hormone levels are associated with clinical markers and cytokine levels in human localized cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Antioxidants and proinflamatory cytokines in the sera of patients with cutaneous leishmaniasis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Serum chemokine profiles in visceral leishmaniasis, HIV and HIV/ visceral leishmaniasis co-infected Ethiopian patients

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Evaluation of latex agglutination test (KAtex) for early diagnosis of kala-azar

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Cutaneous leishmaniasis caused by Leishmania tropica in Bikaner, India: parasite identification and characterization using molecular and immunologic tools.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Reference values for Leishmania infantum parasitemia in different clinical presentations: quantitative polymerase chain reaction for therapeutic monitoring and patient follow-up.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Detection of leishmanial antigen in the urine of patients with visceral leishmaniasis by a latex agglutination test.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Field evaluation of latex agglutination test for detecting urinary antigens in visceral leishmaniasis in Sudan.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Evaluation of a latex agglutination test (KAtex) for detection of Leishmania antigen in urine of patients with HIV-Leishmania coinfection: value in diagnosis and post-treatment follow-up

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Serodiagnosis of leishmaniasis with recombinant ORFF antigen.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Splenic aspiration; experience in Kenya.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291336

Elevated levels of interferon-γ, interleukin-10, and interleukin-6 during active disease in Indian kala azar

28 November 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Circulating nitric oxide and C-reactive protein levels in Indian kala azar patients: Correlation with clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Presence of anti-Lepp12 antibody: a marker for diagnostic and prognostic evaluation of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Comparison of flow cytometry and indirect immunofluorescence assay in the diagnosis and cure criterion after therapy of American tegumentary leishmaniasis by anti-live Leishmania (Viannia) braziliensis immunoglobulin G

21 January 2018

1 reference

https://api.crossref.org/works/10.1128%2FAAC.04298-14

Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis

21 January 2018

1 reference

12 December 2020

Associations among plasma selenium, zinc, copper, and iron concentrations and immunoregulatory cytokine levels in patients with cutaneous leishmaniasis

1 reference

12 December 2020

Serum nitrite level and adenosine deaminase activity is altered in visceral leishmaniasis

1 reference

12 December 2020

Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients

1 reference

12 December 2020

High concentration of adenosine in human visceral leishmaniasis despite increased ADA and decreased CD73

1 reference

12 December 2020

Distinct pattern of immunophenotypic features of innate and adaptive immunity as a putative signature of clinical and laboratorial status of patients with localized cutaneous leishmaniasis

1 reference

12 December 2020

Anti-leishmanial IgE antibodies: a marker of active disease in visceral leishmaniasis

1 reference

12 December 2020

Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania c

1 reference

12 December 2020

Plasma sCD26 and sCD30 levels in cutaneous leishmaniasis

1 reference

12 December 2020

Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis

1 reference

12 December 2020

Short report: persistence of tumor necrosis factor-alpha in situ after lesion healing in mucosal leishmaniasis

1 reference

12 December 2020

Serum levels of tumor necrosis factor in patients with American cutaneous leishmaniasis

1 reference

12 December 2020

Variations in the serum levels of soluble CD23, nitric oxide and IgE across the spectrum of American cutaneous leishmaniasis

1 reference

12 December 2020

Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis

1 reference

12 December 2020

Plasma levels of tumor necrosis factor-alpha in patients with visceral leishmaniasis (Kala-azar). Association with activity of the disease and clinical remission following antimonial therapy

1 reference

12 December 2020

In situ expression of interleukin-10 and interleukin-12 in active human cutaneous leishmaniasis

1 reference

12 December 2020

Compararative evaluation of rK9, rK26 and rK39 antigens in the serodiagnosis of Indian visceral leishmaniasis

1 reference

12 December 2020

Significance of persistence of antibodies against Leishmania infantum in sicilian patients affected by acute visceral leishmaniasis

1 reference

12 December 2020

Therapeutic failure in American cutaneous leishmaniasis is associated with gelatinase activity and cytokine expression

1 reference

12 December 2020

Rapid diagnosis of Indian visceral leishmaniasis using achatininH, a 9-O-acetylated sialic acid binding lectin

1 reference

12 December 2020

Low serum levels of dehydroepiandrosterone and cortisol in human diffuse cutaneous leishmaniasis by Leishmania mexicana

1 reference

12 December 2020

Soluble CD26 and CD30 levels in patients with anthroponotic cutaneous leishmaniasis

1 reference

12 December 2020

Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis

1 reference

12 December 2020

Evaluation of serological markers to monitor the disease status of Indian post kala-azar dermal leishmaniasis.

1 reference

12 December 2020

Dynamics of serum cytokines in patients with visceral leishmaniasis and HIV-1 co-infection

1 reference

12 December 2020

Local immunological factors associated with recurrence of mucosal leishmaniasis

1 reference

12 December 2020

Serum concentrations of soluble intercellular adhesion molecule-1 and progress towards disease in patients infected with HIV

1 reference

12 December 2020

Cytokines and visceral leishmaniasis: a comparison of plasma cytokine profiles between the clinical forms of visceral leishmaniasis

1 reference

12 December 2020

Adenosine deaminase activities in sera, lymphocytes and granulocytes in patients with cutaneous leishmaniasis

1 reference

12 December 2020

IL-15 in human visceral leishmaniasis caused by Leishmania infantum

1 reference

12 December 2020

Miltefosine effectively modulates the cytokine milieu in Indian post kala-azar dermal leishmaniasis

1 reference

12 December 2020

Reactive nitrogen and oxygen intermediates in patients with cutaneous leishmaniasis

1 reference

12 December 2020

Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis

1 reference

12 December 2020

Usefulness of sampling with cotton swab for PCR-diagnosis of cutaneous leishmaniasis in the New World

1 reference

12 December 2020

Acute phase protein concentrations predict parasite clearance rate during therapy for visceral leishmaniasis

1 reference

12 December 2020

Tumor necrosis factor-alpha in human american tegumentary leishmaniasis

1 reference

12 December 2020

Circulating levels of sTNFR and discrepancy between cytotoxicity and immunoreactivity of TNF-alpha in patients with visceral leishmaniasis

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.04298-14

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367913%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25367913%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

2 references